ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

OPGN OpGen Inc

0,449
-0,086 (-16,07%)
01 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
OpGen Inc OPGN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,086 -16,07% 0,449 01:44:30
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,50 0,4026 0,50 0,403 0,535
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.4.202422:05GLOBEOpGen Provides Update on Business Operations and Strategic..
23.4.202422:15GLOBEOpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
26.3.202421:20APSShares Rip In Reaction To Activist Investor Becoming CEO
25.3.202421:05GLOBEOpGen Announces Acquisition of Preferred Stock by David..
13.2.202422:30EDGAR2Form 8-K - Current report
08.2.202413:30EDGAR2Form 8-K - Current report
09.1.202422:30EDGAR2Form 8-K - Current report
12.12.202322:58EDGAR2Form 8-K - Current report
05.12.202322:37EDGAR2Form 8-K - Current report
24.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
14.11.202322:30GLOBEOpGen Reports Third Quarter 2023 Financial Results and..
13.11.202322:59EDGAR2Form S-3 - Registration statement under Securities Act of..
07.11.202322:30EDGAR2Form 8-K - Current report
26.10.202322:30EDGAR2Form 8-K - Current report
16.10.202322:30EDGAR2Form 8-K - Current report
13.10.202323:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13.10.202323:17EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13.10.202323:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13.10.202323:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13.10.202323:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12.10.202318:32GLOBEOpGen Enters Into Warrant Inducement Transaction for up to..
11.10.202322:40EDGAR2Form 8-K - Current report
11.10.202322:30EDGAR2Form 8-K - Current report
28.9.202322:24EDGAR2Form RW - Registration Withdrawal Request
08.9.202322:30EDGAR2Form 8-K - Current report
07.9.202322:30EDGAR2Form 8-K - Current report
14.8.202314:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202322:31EDGAR2Form 8-K - Current report
10.8.202322:15GLOBEOpGen Reports Second Quarter 2023 Financial Results and..
07.8.202313:30GLOBEOpGen’s Subsidiary Ares Genetics Releases New Features to..
03.8.202314:00GLOBEOpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration..
03.8.202313:30GLOBEOpGen to Provide Business Update and Financial Results for..
01.8.202315:40EDGAR2Form DEF 14A - Other definitive proxy statements
21.7.202322:55EDGAR2Form PRE 14A - Other preliminary proxy statements
19.7.202313:30GLOBEOpGen’s Subsidiary Curetis Meets Milestones of Extended and..
14.7.202322:30EDGAR2Form S-1 - General form for registration of securities under..
05.7.202322:30EDGAR2Form 8-K - Current report
30.6.202322:30EDGAR2Form 8-K - Current report
26.6.202313:30GLOBEOpGen Subsidiary Ares Genetics Successfully Maintains Key..
22.6.202313:30GLOBEOpGen’s Subsidiary Curetis Receives Batch of Ten New..
20.6.202313:30GLOBEOpGen Presents Unyvero Urinary Tract Infection Panel Trial..
15.5.202322:15GLOBEOpGen Reports First Quarter 2023 Financial Results and..
08.5.202313:30GLOBEOpGen to Provide Business Update and Financial Results for..
04.5.202322:30GLOBEOpGen Announces Closing of $3.5 Million Public Offering
02.5.202303:00GLOBEOpGen Announces Pricing of $3.5 Million Public Offering

Kürzlich von Ihnen besucht

Delayed Upgrade Clock